A proposed class of health benefit plans, suing as indirect purchasers of Celebrex, had their claims dismissed in February. Read more
It was reported that the Celebrex settlement is likely among the last major payments Pfizer will make over the two drugs. Read more
It’s believed this settlement is likely among the last major payments Pfizer will make over the two drugs. Read more
Pfizer also paid $1 billion to settle civil cases alleging it fraudulently promoted and marketed Bextra. Read more
A U.S. Food and Drug Administration (FDA) panel has voted that there is not enough scientific proof to support claims that naproxen, a painkiller sold as Aleve by Bayer Corp., is safer than... Read more
Pfizer Inc. has failed to persuade a federal judge to dismiss a shareholder lawsuit accusing the company of fraudulently misrepresenting the safety of its Celebrex and Bextra pain-relieving... Read more
Pfizer Inc. has agreed to pay $164 million to settle a shareholder class action accusing the drug maker of misrepresenting the clinical trial results for Celebrex. The settlement was disclos... Read more
Brigham Young University and Pfizer Inc., the giant drug manufacturer, have settled a lawsuit for $450 million. At issue was whether BYU had been cheated out of billions of dollars in royalt... Read more
A Danish study, released last month, found that heart attack and heart failure patients have a higher risk of a second heart attack or death if they take painkillers, including Celebrex and... Read more
Before joining our firm, Frank Woodson was a partner in the general litigation firm of Turner, Onderdonk, Kimbrough & Howell in Mobile, Alabama, where his practice focused on litigation... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.